Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Standaert

Showing results (151-160 of 188) with videos related to

Pageof 19
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|September 10, 2013
Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefitKaren L Eskow Jaunarajs, David G Standaert, Tacey X Viegas, et al.
Journal of Parkinson'S Disease|January 2, 2022
Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal GelNorbert Kovács, Lars Bergmann, Marieta Anca-Herschkovitsch, et al.
Journal of Parkinson'S Disease|June 19, 2023
What Patients Say: Large-Scale Analyses of Replies to the Parkinson's Disease Patient Report of Problems (PD-PROP)Connie Marras, Lakshmi Arbatti, Abhishek Hosamath, et al.
Neurobiology of Disease|March 16, 2010
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystoniaFrancesco Napolitano, Massimo Pasqualetti, Alessandro Usiello, et al.
Movement Disorders Clinical Practice|October 11, 2021
DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's DiseaseDavid G Standaert, Jason Aldred, Marieta Anca-Herschkovitsch, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammationYuan Yuan, Huizhong Li, Kashyap Sreeram, et al.
The Lancet. Neurology|December 24, 2013
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy studyC Warren Olanow, Karl Kieburtz, Per Odin, et al.
Molecular Neurodegeneration|June 11, 2024
Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammationYuan Yuan, Huizhong Li, Kashyap Sreeram, et al.
Plos One|October 7, 2009
Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegenerationKim A Caldwell, Michelle L Tucci, Jafa Armagost, et al.
Journal of Parkinson'S Disease|April 7, 2020
Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort ExperienceRoseanne D Dobkin, Ninad Amondikar, Catherine Kopil, et al.
Pageof 19

Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
Movement Disorders : Official Journal of the Movement Disorder Society|September 10, 2013
Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefitKaren L Eskow Jaunarajs, David G Standaert, Tacey X Viegas, et al.
Journal of Parkinson'S Disease|January 2, 2022
Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal GelNorbert Kovács, Lars Bergmann, Marieta Anca-Herschkovitsch, et al.
Journal of Parkinson'S Disease|June 19, 2023
What Patients Say: Large-Scale Analyses of Replies to the Parkinson's Disease Patient Report of Problems (PD-PROP)Connie Marras, Lakshmi Arbatti, Abhishek Hosamath, et al.
Neurobiology of Disease|March 16, 2010
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystoniaFrancesco Napolitano, Massimo Pasqualetti, Alessandro Usiello, et al.
Movement Disorders Clinical Practice|October 11, 2021
DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's DiseaseDavid G Standaert, Jason Aldred, Marieta Anca-Herschkovitsch, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammationYuan Yuan, Huizhong Li, Kashyap Sreeram, et al.
The Lancet. Neurology|December 24, 2013
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy studyC Warren Olanow, Karl Kieburtz, Per Odin, et al.
Molecular Neurodegeneration|June 11, 2024
Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammationYuan Yuan, Huizhong Li, Kashyap Sreeram, et al.
Plos One|October 7, 2009
Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegenerationKim A Caldwell, Michelle L Tucci, Jafa Armagost, et al.
Journal of Parkinson'S Disease|April 7, 2020
Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort ExperienceRoseanne D Dobkin, Ninad Amondikar, Catherine Kopil, et al.
Pageof 19